Semaglutide treatment of hypothalamic obesity – a real-life data study
Treatment with semaglutide shows promising results in reducing body weight in patients with acquired hypothalamic obesity. Whether the weight reduction remains stable after long time follow-up needs further investigation.
Authors
- Mathilde Svendstrup (ORCID: https://orcid.org/0000-0002-9176-1707)
- Caroline Kistorp (ORCID: https://orcid.org/0000-0002-3019-6775)
- Marianne Klose (ORCID: https://orcid.org/0000-0001-6075-0821)
- Mikkel Andreassen (ORCID: https://orcid.org/0000-0002-1656-3516)
- Aase Krogh Rasmussen
Institutions
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Pituitary
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1007/s11102-024-01429-5
- Citations
- 14
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.01
Funders
- Rigshospitalet